A combination of in vitro comet assay and micronucleus test using human lymphoblastoid TK6 cells

Mutagenesis

Volumn 28, Issue 5, 2013, Pages 583-590

  Kimura, Aoi ^a,b,c   Miyata, Atsuro ^b   Honma, Masamitsu ^c  

^a SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; MITOMYCIN; TRITON X 100;

ARTICLE; CELL ASSAY; CELL SCREENING; CELLULAR PARAMETERS; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DNA DAMAGE; GAMMA RADIATION; GENOTOXICITY; HAZARD ASSESSMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; LYMPHOBLASTOID TK6 CELL; MICRONUCLEUS; MICRONUCLEUS TEST; PRIORITY JOURNAL; RELATIVE CELL COUNT; RELATIVE CELL VIABILITY; RELATIVE INCREASE IN CELL COUNT; RELATIVE POPULATION DOUBLING; SENSITIVITY ANALYSIS; TRYPAN BLUE DYE EXCLUSION ASSAY;

CELL SURVIVAL; CELLS, CULTURED; COMET ASSAY; CROSS-LINKING REAGENTS; CYTOTOXINS; ETHYL METHANESULFONATE; GAMMA RAYS; HUMANS; HYDROGEN PEROXIDE; METHYL METHANESULFONATE; MICRONUCLEUS TESTS; MITOMYCIN; MUTAGENICITY TESTS; MUTAGENS; OCTOXYNOL; SENSITIVITY AND SPECIFICITY;

EID: 84882739461     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/get036     Document Type: Article

References (29)

1. Ostling, O. and Johanson, K. J. (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Commun., 123, 291-298
2. Singh, N. P., McCoy, M. T., Tice, R. R. and Schneider, E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191
3. Olive, P. L. and Banáth, J. P. (2006) The comet assay: A method to measure DNA damage in individual cells. Nat. Protoc., 1, 23-29
4. Tice, R. R., Agurell, E., Anderson, D., et al. (2000) Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen., 35, 206-221
5. OECD (2012) Draft OECD Guideline for the Testing of Chemicals, Rodent Alkaline Single Cell Gel Electrophoresis (Comet) assay. http://www.oecd. org/env/ehs/testing/OECD-draft-Comet%5B1%5D.pdf
6. Kimura, A., Torigoe, N., Miyata, A. and Honma, M. (2010) Validation of a simple comet assay method using CHL cells. Genes Environ., 32, 61-65
7. Kirsch-Volders, M. (1997) Towards a validation of the micronucleus test. Mutat. Res., 392, 1-4
8. Matsuoka, A., Yamazaki, N., Suzuki, T., Hayashi, M. and Sofuni, T. (1992) Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res., 272, 223-236
9. Parry, J. M. and Sors, A. (1993) The detection and assessment of the aneugenic potential of environmental chemicals: The European Community Aneuploidy Project. Mutat. Res., 287, 3-15
10. OECD (2012) OECD Guideline for the Testing of Chemicals, Proposal for Updating Test Guideline 487, In Vitro Mammalian Cell Micronucleus Test. http://www.oecd.org/env/ehs/testing/TG487%20Oct%202012%20 updated%2029oct.pdf
11. Hartmann, A., Plappert, U., Poetter, F. and Suter, W. (2003) Comparative study with the alkaline Comet assay and the chromosome aberration test. Mutat. Res., 536, 27-38
12. Kirkland, D. (2010) Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): Summary of results in the collaborative trial. Mutat. Res., 702, 139-147
13. Liber, H. L. and Thilly, W. G. (1982) Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. Mutat. Res., 94, 467-485
14. Honma, M. and Hayashi, M. (2011) Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells. Environ. Mol. Mutagen., 52, 373-384
15. Fellows, M. D., O'Donovan, M. R., Lorge, E. and Kirkland, D. (2008) Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. II: Practical aspects with toxic agents. Mutat. Res., 655, 4-21
16. Greenwood, S. K., Hill, R. B., Sun, J. T., Armstrong, M. J., Johnson, T. E., Gara, J. P. and Galloway, S. M. (2004) Population doubling: A simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environ. Mol. Mutagen., 43, 36-44
17. Honma, M. (2005) Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells. Environ. Mol. Mutagen., 45, 162-176
18. Fowler, P., Smith, K., Young, J., Jeffrey, L., Kirkland, D., Pfuhler, S. and Carmichael, P. (2012) Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutat. Res., 742, 11-25
19. Greenwood, S. K., Armstrong, M. J., Hill, R. B., Bradt, C. I., Johnson, T. E., Hilliard, C. A. and Galloway, S. M. (1998) Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Mutat. Res., 401, 39-53
20. Olive, P. L., Frazer, G. and Banáth, J. P. (1993) Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res., 136, 130-136
21. Amundson, S. A., Do, K. T., Vinikoor, L., Koch-Paiz, C. A., Bittner, M. L., Trent, J. M., Meltzer, P. and Fornace, A. J. Jr. (2005) Stress-specific signatures: Expression profiling of p53 wild-type and -null human cells. Oncogene, 24, 4572-4579
22. Hastwell, P. W., Webster, T. W., Tate, M., Billinton, N., Lynch, A. M., Harvey, J. S., Rees, R. W. and Walmsley, R. M. (2009) Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay. Mutagenesis, 24, 455-463
23. Witte, I., Plappert, U., de Wall, H. and Hartmann, A. (2007) Genetic toxicity assessment: Employing the best science for human safety evaluation part III: The comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Toxicol. Sci., 97, 21-26
24. Giannotti, E., Vandin, L., Repeto, P. and Comelli, R. (2002) A comparison of the in vitro Comet assay with the in vitro chromosome aberration assay using whole human blood or Chinese hamster lung cells: Validation study using a range of novel pharmaceuticals. Mutagenesis, 17, 163-170
25. Kawaguchi, S., Nakamura, T., Yamamoto, A., Honda, G. and Sasaki, Y. F. (2010) Is the comet assay a sensitive procedure for detecting genotoxicity? J. Nucleic Acids, 2010, 541050
26. Henderson, L., Wolfreys, A., Fedyk, J., Bourner, C. and Windebank, S. (1998) The ability of the Comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis, 13, 89-94
27. Rossman, T. G. (2009) Inappropriate cytotoxicity measurements. Environ. Mol. Mutagen., 50, 81
28. Shi, J., Springer, S. and Escobar, P. (2010) Coupling cytotoxicity biomarkers with DNA damage assessment in TK6 human lymphoblast cells. Mutat. Res., 696, 167-178
29. Honma, M. (2011) Cytotoxicity measurement in in vitro chromosome aberration test and micronucleus test. Mutat. Res., 724, 86-87